Alx Oncology Holdings (ALXO) Return on Capital Employed (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,197.00 |
| Dec 31, 2025 | -4,244.00 |
| Sep 30, 2025 | -4,580.00 |
| Jun 30, 2025 | -1,818.00 |
| Mar 31, 2025 | -2,200.00 |
| Dec 31, 2024 | -8,218.00 |
| Sep 30, 2024 | 1,124.00 |
| Jun 30, 2024 | -503.00 |
| Mar 31, 2024 | -284.00 |
| Dec 31, 2023 | 6,078.00 |
| Sep 30, 2023 | -2,166.00 |
| Jun 30, 2023 | -652.00 |
| Mar 31, 2023 | -497.00 |
| Dec 31, 2022 | -457.00 |
| Sep 30, 2022 | -662.00 |
| Jun 30, 2022 | -734.00 |
| Mar 31, 2022 | -408.00 |
| Dec 31, 2021 | -1,255.00 |
| Sep 30, 2021 | -393.00 |
| Jun 30, 2021 | -141.00 |
| Mar 31, 2021 | -162.00 |
| Dec 31, 2020 | 1,633.00 |